Mesenchymal Stem Cells in the Treatment of Refractory Primary Immune Thrombocytopenia

NCT06813157 · clinicaltrials.gov ↗

NA

Phase

RECRUITING

Status

40

Enrollment

INDUSTRY

Sponsor class

Conditions

ITP - Immune Thrombocytopenia

Interventions

OTHER: MSC

Sponsor

Guangzhou Bio-gene Technology Co., Ltd